Circulating Tumor DNA Clinical Trials

42 clinical trials for Circulating Tumor DNA across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial — RECRUITING · NA
• Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) — RECRUITING · PHASE2
• Danish Vulva Cancer Recurrence Study — RECRUITING · NA
• CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer — RECRUITING
• NSCLC Liquid Biopsies and Exhaled VOC — RECRUITING
• Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling — RECRUITING
• Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer — RECRUITING · NA
• Using ctDNA to Determine Therapies for Lung Cancer — RECRUITING · PHASE2
• ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases — RECRUITING
• Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer — RECRUITING · PHASE2
• Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) — RECRUITING
• Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer — RECRUITING · NA
• Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma. — TERMINATED · NA
• Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection — COMPLETED · PHASE3
• Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients — OTHER
• Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases — COMPLETED
• Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer. — COMPLETED
• Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology — OTHER
• Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA) — OTHER
• ctDNA Methylation for Epithelial Ovarian Cancer — OTHER
• ctDNA Methylation for Detecting Ovarian Cancer — OTHER
• Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer — OTHER
• OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - — COMPLETED
• Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. — COMPLETED · NA
• Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules — OTHER · NA
• Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer — COMPLETED
• Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer — COMPLETED
• Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization — OTHER
• Detection of Plasma Circulating Tumor DNA in Gastric Cancer — OTHER
• An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease — WITHDRAWN · PHASE2
• IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer — OTHER · PHASE2
• Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC — OTHER
• Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study — OTHER · NA
• The Value of ctDNA on Chemotherapy Efficacy for mCRC — OTHER · NA
• WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC — OTHER · NA
• CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer — COMPLETED · NA
• Methylation Analysis of Circulating Tumor DNA in Gastric Cancer — OTHER
• Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy — OTHER
• Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients — OTHER
• Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer — OTHER
• Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients — OTHER
• Concordance Between ctDNA Assay and FoundationOne — COMPLETED

Refine this search